✦ LIBER ✦

Induction of complete remission of acute myeloid leukaemia by pegylated interferon-α-2a in a patient with transformed primary myelofibrosis

✍ Scribed by Zwi N. Berneman; Sébastien Anguille; Veerle Van Marck; Wilfried A. Schroyens; Viggo F. Van Tendeloo

Book ID: 108676627
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 297 KB
Volume: 149
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2009.08029.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of complete remission in a pat

Induction of complete remission in a patient with acute myeloid leukemia refractory to high-dose chemotherapy through treatment with 5-azacytidine

✍ A. Kuendgen; T. Gräf; F. Zohren; B. Hildebrandt; A. Hünerlitürkoglu; N. Gatterma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 654 KB

For patients with acute myeloid leukemia refractory to intensive chemotherapy prognosis is very poor and treatment options are limited. 5-Azacytidine, a demethylating drug, is effective in the treatment of myelodysplastic syndromes when administered at a low-dose, subcutaneously. We report a case of

Complete remission in a patient with rec

Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity

✍ Mailänder, V; Scheibenbogen, C; Thiel, E; Letsch, A; Blau, I W; Keilholz, U 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Adult patients with acute myeloid leukem

Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis : A report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group

✍ Jacob M. Rowe; Haesook T. Kim; Peter A. Cassileth; Hillard M. Lazarus; Mark R. L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

Autologous bone marrow transplantation a

Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch–Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial

✍ Dimitri A. Breems; Marc A. Boogaerts; Adriaan W. Dekker; Wim L. J. Van Putten; P 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB